| Synonym | Cell Type | QPCR Expression | Normalized To | Data From |
|---|
| Zfp109 | DN1 | -1.89 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp109 | DN1 | -2.17 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp109 | DN1 | -4 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| . | | | | |
| Zfp109 | DN2 | -2.03 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp109 | DN2 | -2.13 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp109 | DN2 | -2.77 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| . | | | | |
| Zfp109 | DN3a | -1.96 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp109 | DN3a | -2.11 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp109 | DN3a | -2.17 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| . | | | | |
| Zfp109 | DN3b | -2.34 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp109 | DN3b | -2.48 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp109 | DN3b | -2.59 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| . | | | | |
| Zfp109 | DN4 | -2.25 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp109 | DN4 | -2.82 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp109 | DN4 | -2.72 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| . | | | | |
| Zfp109 | LSK- | -2.77 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp109 | LSK- | -2.77 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp109 | LSK- | -2.74 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp109 | LSK- | -2.27 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| Zfp109 | LSK- | -2.14 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| Zfp109 | LSK- | -2.15 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| . | | | | |
| Zfp109 | LSK+ | -2.27 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp109 | LSK+ | -2.14 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp109 | LSK+ | -2.15 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp109 | LSK+ | -2.77 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| Zfp109 | LSK+ | -2.77 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| Zfp109 | LSK+ | -2.74 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| . | | | | |
| Zfp109 | PreM | -3.4 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp109 | PreM | -3.07 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp109 | PreM | -3.48 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp109 | PreM | -3.4 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| Zfp109 | PreM | -3.07 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| Zfp109 | PreM | -3.48 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| . | | | | |
| Zfp109 | ProB | -2.8 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp109 | ProB | -3 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp109 | ProB | -2.96 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Zfp109 | ProB | -2.8 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| Zfp109 | ProB | -3 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| Zfp109 | ProB | -3.77 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| . | | | | |
| Zfp109 | ProT | -2.27 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| Zfp109 | ProT | -2.14 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| Zfp109 | ProT | -2.09 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |